0001638599-16-000925.txt : 20160525
0001638599-16-000925.hdr.sgml : 20160525
20160525163529
ACCESSION NUMBER: 0001638599-16-000925
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160524
FILED AS OF DATE: 20160525
DATE AS OF CHANGE: 20160525
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1430 HIGHWAY 206
STREET 2: SUITE 200
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 1430 HIGHWAY 206
STREET 2: SUITE 200
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pfaffle Antony
CENTRAL INDEX KEY: 0001368953
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 161675052
MAIL ADDRESS:
STREET 1: C/O INNOVIVE PHARMACEUTICALS, INC.
STREET 2: 555 MADISON AVENUE, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4_3979.xml
PRIMARY DOCUMENT
X0306
4
2016-05-24
0
0001410098
CorMedix Inc.
CRMD
0001368953
Pfaffle Antony
C/O CORMEDIX INC.
745 ROUTE 202-206, SUITE 303
BRIDGEWATER
NJ
08807
1
1
0
0
Interim Chief Medical Officer
Common Stock, $0.001 par value per share
2016-05-24
4
M
0
12700
0.68
A
12700
D
Common Stock, $0.001 par value per share
2016-05-24
4
S
0
5000
2.7103
D
7700
D
Common Stock, $0.001 par value per share
2016-05-24
4
S
0
5000
2.708
D
2700
D
Common Stock, $0.001 par value per share
2016-05-24
4
S
0
2700
2.8015
D
0
D
Stock Option (right to buy)
2.27
2024-04-01
Common Stock, $0.001 par value per share
100000
100000
D
Stock Option (right to buy)
2.02
2024-01-09
Common Stock, $0.001 par value per share
100000
100000
D
Stock Option (right to buy)
2.02
2024-01-09
Common Stock, $0.001 par value per share
30000
30000
D
Stock Option (right to buy)
0.9
2023-03-22
Common Stock, $0.001 par value per share
210000
210000
D
Stock Option (right to buy)
0.68
2016-05-24
4
M
0
12700
0
A
2022-12-05
Common Stock, $0.001 par value per share
162700
150000
D
Stock Option (right to buy)
2.1
2021-01-14
Common Stock, $0.001 par value per share
30000
30000
D
Stock Option (right to buy)
3.125
2020-03-30
Common Stock, $0.001 par value per share
20000
20000
D
Stock Option (right to buy)
5
2025-02-24
Common Stock, $0.001 par value per share
75000
75000
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.76, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.72, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $2.82, inclusive.
The options vested 100% on April 2, 2014.
The options vested 100% on January 10, 2014.
The options vest in full on the first anniversary of the date of grant.
These options vest based on performance milestones running through December 31, 2014.
These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013.
These options vested on January 14, 2012.
These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.
These options were granted on February 24, 2015, and vested immediately.
Alexander M. Donaldson, with a Power of Attorney for Antony E. Pfaffle, M.D.
2016-05-25